Track topics on Twitter Track topics that are important to you
Allergan reported its second quarter 2017 operations performance, including total net revenues of $4 billion, which was a 9% increase from the same quarter a year earlier.The revenue growth was driven by Botox (onabotulinumtoxinA) and the Juvederm (injectible gel) collection, and the addition of Alloderm (tissue matrix) and CoolSculpting (cryolipolysis), according to a news release from Allergan.
Original Article: Allergan reports Q2 net revenue increaseNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...